Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radio-labelled TP05 (Mesalazine) in Healthy Subjects
NCT02306772Phase 1Completed
- Sponsor
- Tillotts Pharma AG
- Start
- Dec 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of Salcrozine in ulcerative colitis (UC) (2 arms), sponsored by Tillotts Pharma AG. Primary endpoint: Tablet release at 3 days. Started Dec 2011; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02306772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306772.